Profile data is unavailable for this security.
About the company
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
- Revenue in USD (TTM)399.25m
- Net income in USD-30.44m
- Incorporated2000
- Employees1.20k
- LocationAtriCure Inc7555 Innovation WayMASON 45040United StatesUSA
- Phone+1 (513) 755-4100
- Fax+1 (513) 755-4567
- Websitehttps://www.atricure.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Atrion Corp | 169.33m | 19.41m | 720.05m | 712.00 | 37.12 | 2.96 | 20.87 | 4.25 | 11.02 | 11.02 | 96.13 | 138.01 | 0.6444 | 1.44 | 7.21 | 237,817.40 | 7.39 | 11.96 | 7.85 | 12.62 | 36.84 | 41.99 | 11.46 | 19.05 | 2.57 | 92.92 | 0.00 | 42.42 | -7.73 | 2.12 | -44.55 | -10.74 | 4.98 | 11.27 |
| BioLife Solutions Inc | 143.27m | -66.43m | 724.80m | 409.00 | -- | 2.14 | -- | 5.06 | -1.52 | -1.52 | 3.28 | 7.48 | 0.332 | 2.46 | 5.45 | 350,298.30 | -15.40 | -13.76 | -17.12 | -15.04 | 32.63 | 36.76 | -46.36 | -42.99 | 1.83 | -30.52 | 0.0733 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
| Cytek Biosciences Inc | 193.01m | -12.15m | 781.02m | 676.00 | -- | 1.99 | -- | 4.05 | -0.0887 | -0.0887 | 1.43 | 3.01 | 0.3807 | 1.53 | 3.68 | 285,523.70 | -2.40 | -- | -2.67 | -- | 56.69 | -- | -6.29 | -- | 5.89 | -- | 0.0056 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
| Paragon 28 Inc | 216.39m | -47.84m | 799.22m | 430.00 | -- | 4.49 | -- | 3.69 | -0.5819 | -0.5819 | 2.64 | 2.15 | 0.7276 | 0.5484 | 5.77 | 503,230.20 | -16.09 | -- | -20.14 | -- | 79.85 | -- | -22.11 | -- | 2.30 | -7.22 | 0.3832 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
| Artivion Inc | 354.00m | -30.57m | 847.13m | 1.50k | -- | 2.96 | -- | 2.39 | -0.7496 | -0.7496 | 8.68 | 6.86 | 0.4553 | 1.60 | 5.30 | 236,002.70 | -3.95 | -2.20 | -4.24 | -2.36 | 64.74 | 65.51 | -8.67 | -5.34 | 3.43 | 0.6809 | 0.5246 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| Perspective Therapeutics Inc | 8.17m | -25.10m | 856.90m | 88.00 | -- | 4.15 | -- | 104.87 | -0.1012 | -0.1012 | 0.0351 | 0.352 | 0.0944 | 4.91 | 5.55 | 92,852.27 | -29.01 | -- | -31.19 | -- | 22.96 | -- | -307.18 | -- | 2.55 | -- | 0.0173 | -- | -- | -- | -- | -- | -- | -- |
| Avanos Medical Inc | 673.30m | -9.90m | 861.71m | 3.77k | -- | 0.6966 | 23.80 | 1.28 | -0.2092 | -1.32 | 14.43 | 26.77 | 0.387 | 1.66 | 4.73 | 178,546.80 | -0.5691 | -0.6527 | -0.6473 | -0.7338 | 56.39 | 54.45 | -1.47 | -1.60 | 1.38 | 4.27 | 0.1196 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| MiMedx Group Inc | 321.48m | 55.80m | 915.55m | 895.00 | 24.14 | 6.38 | 14.28 | 2.85 | 0.2581 | 0.2192 | 2.19 | 0.976 | 1.57 | 3.19 | 6.63 | 359,192.20 | 32.86 | -4.14 | 42.03 | -5.90 | 83.01 | 83.61 | 20.98 | -2.70 | 3.11 | 7.11 | 0.256 | -- | 20.03 | -2.19 | 310.29 | -- | -26.47 | -- |
| AtriCure Inc | 399.25m | -30.44m | 1.12bn | 1.20k | -- | 2.36 | -- | 2.80 | -0.6569 | -0.6569 | 8.62 | 9.81 | 0.6658 | 1.74 | 8.39 | 332,704.20 | -5.08 | -3.72 | -5.71 | -4.10 | 75.23 | 74.36 | -7.62 | -7.64 | 2.66 | -8.52 | 0.1301 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| Coretag Inc | 0.00 | -39.35k | 1.13bn | -- | -- | -- | -- | -- | -0.4372 | -0.4372 | 0.00 | -0.93 | 0.00 | -- | -- | -- | -78,700.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.95 | -- | -- | -- |
| Adapthealth Corp | 3.20bn | -678.90m | 1.28bn | 10.70k | -- | 0.874 | -- | 0.3991 | -5.06 | -5.06 | 23.77 | 11.00 | 0.6579 | 21.79 | 8.56 | 299,082.00 | -13.87 | -4.34 | -15.48 | -4.89 | 17.82 | 18.28 | -21.09 | -6.47 | 0.997 | 1.83 | 0.5978 | -- | 7.73 | -- | -1,169.99 | -- | -- | -- |
| Establishment Labs Holdings Inc | 165.15m | -78.50m | 1.42bn | 908.00 | -- | 73.38 | -- | 8.60 | -3.05 | -3.05 | 6.45 | 0.7051 | 0.6886 | 1.00 | 4.01 | 181,884.40 | -32.73 | -33.22 | -40.93 | -41.12 | 64.78 | 64.73 | -47.53 | -43.19 | 1.67 | -13.08 | 0.9112 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
| LeMaitre Vascular Inc | 193.48m | 30.11m | 1.43bn | 614.00 | 47.76 | 4.81 | 36.15 | 7.40 | 1.34 | 1.34 | 8.63 | 13.34 | 0.5888 | 1.23 | 8.22 | 315,120.50 | 9.16 | 9.02 | 10.00 | 9.93 | 65.66 | 65.83 | 15.56 | 15.45 | 4.57 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| Warby Parker Inc | 669.77m | -63.20m | 1.49bn | 2.14k | -- | 4.94 | -- | 2.22 | -0.5376 | -0.5376 | 5.71 | 2.55 | 1.17 | 4.65 | 416.78 | 312,974.30 | -11.00 | -- | -14.16 | -- | 54.53 | 57.49 | -9.44 | -14.53 | 1.86 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| Inmode Ltd | 492.05m | 197.92m | 1.49bn | 581.00 | 7.64 | 1.88 | 7.51 | 3.03 | 2.30 | 2.30 | 5.73 | 9.38 | 0.6527 | 1.90 | 14.19 | 846,898.40 | 26.25 | 31.32 | 29.07 | 35.64 | 83.60 | 84.46 | 40.22 | 39.65 | 12.48 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
Data as of Apr 17 2024. Currency figures normalised to AtriCure Inc's reporting currency: US Dollar USD
44.56%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 4.64m | 9.76% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 3.54m | 7.44% |
| AllianceBernstein LPas of 31 Dec 2023 | 3.39m | 7.13% |
| Champlain Investment Partners LLCas of 31 Dec 2023 | 2.11m | 4.42% |
| Macquarie Investment Management Business Trustas of 31 Dec 2023 | 1.45m | 3.05% |
| First Light Asset Management LLCas of 31 Dec 2023 | 1.35m | 2.84% |
| Wellington Management Co. LLPas of 31 Dec 2023 | 1.33m | 2.79% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 1.20m | 2.53% |
| Fred Alger Management LLCas of 31 Dec 2023 | 1.15m | 2.43% |
| Invesco Advisers, Inc.as of 31 Dec 2023 | 1.04m | 2.18% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
